The stock price of Cytokinetics Inc (NASDAQ: CYTK) has dropped by -2.74 compared to previous close of 33.97. Despite this, the company has seen a
Additionally, the 36-month beta value for CYTK is 0.72. There are mixed opinions on the stock, with 10 analysts rating it as a “buy,” 9
The 36-month beta value for CYTK is at 0.71. Analysts have varying views on the stock, with 10 analysts rating it as a “buy,” 9
The stock of Cytokinetics Inc (CYTK) has gone up by 12.74% for the week, with a 6.59% rise in the past month and a -11.94%
Cytokinetics Inc (NASDAQ: CYTK)’s stock price has gone decline by -0.32 in comparison to its previous close of 37.93, however, the company has experienced a
The stock has a 36-month beta value of 0.82. Opinions on the stock are mixed, with 10 analysts rating it as a “buy,” 8 as
The stock has a 36-month beta value of 0.86. Opinions on the stock are mixed, with 10 analysts rating it as a “buy,” 8 as
Cytokinetics Inc (NASDAQ: CYTK)’s stock price has plunge by -6.69relation to previous closing price of 40.19. Nevertheless, the company has seen a -15.82% plunge in
Company’s 36-month beta value is 0.89.Analysts have differing opinions on the stock, with 10 analysts rating it as a “buy,” 8 as “overweight,” 3 as
The 36-month beta value for CYTK is also noteworthy at 0.90. There are mixed opinions on the stock, with 10 analysts rating it as a
© 2024, Powered by Smart TechOne
